255 related articles for article (PubMed ID: 24573150)
1. Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance.
Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X
Oncol Rep; 2014 Apr; 31(4):1669-76. PubMed ID: 24573150
[TBL] [Abstract][Full Text] [Related]
2. Expression of lysyl oxidase in human osteosarcoma and its clinical significance: a tumor suppressive role of LOX in human osteosarcoma cells.
Xu X; Wang B; Xu Y
Int J Oncol; 2013 Nov; 43(5):1578-86. PubMed ID: 23970168
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis].
Liu JL; Wei W; Tang W; Jiang Y; Yang HW; Li JT
Zhonghua Yi Xue Za Zhi; 2012 May; 92(20):1379-83. PubMed ID: 22883193
[TBL] [Abstract][Full Text] [Related]
4. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo.
Dong YD; Cui L; Peng CH; Cheng DF; Han BS; Huang F
Oncol Rep; 2013 Jan; 29(1):87-94. PubMed ID: 23042506
[TBL] [Abstract][Full Text] [Related]
6. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
Zhu J; Huang S; Wu G; Huang C; Li X; Chen Z; Zhao L; Zhao Y
Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020
[TBL] [Abstract][Full Text] [Related]
7. The apoptotic and anti-proliferative effect of Lysyl oxidase propeptide in Y79 human retinoblastoma cells.
Nagaraj NR; Natarajan SK; Karunakaran C
Mol Vis; 2023; 29():125-139. PubMed ID: 38222455
[TBL] [Abstract][Full Text] [Related]
8. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
[TBL] [Abstract][Full Text] [Related]
9. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
10. Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma.
Umezaki N; Nakagawa S; Yamashita YI; Kitano Y; Arima K; Miyata T; Hiyoshi Y; Okabe H; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
Cancer Sci; 2019 Jun; 110(6):2033-2043. PubMed ID: 30919528
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
[TBL] [Abstract][Full Text] [Related]
12. Major Action of Endogenous Lysyl Oxidase in Clear Cell Renal Cell Carcinoma Progression and Collagen Stiffness Revealed by Primary Cell Cultures.
Di Stefano V; Torsello B; Bianchi C; Cifola I; Mangano E; Bovo G; Cassina V; De Marco S; Corti R; Meregalli C; Bombelli S; Viganò P; Battaglia C; Strada G; Perego RA
Am J Pathol; 2016 Sep; 186(9):2473-85. PubMed ID: 27449199
[TBL] [Abstract][Full Text] [Related]
13. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
Liang B; Jia C; Huang Y; He H; Li J; Liao H; Liu X; Liu X; Bai X; Yang D
Dig Dis Sci; 2015 Aug; 60(8):2360-72. PubMed ID: 26025609
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.
Vora SR; Palamakumbura AH; Mitsi M; Guo Y; Pischon N; Nugent MA; Trackman PC
J Biol Chem; 2010 Mar; 285(10):7384-93. PubMed ID: 20048148
[TBL] [Abstract][Full Text] [Related]
15. Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide.
Ozdener GB; Bais MV; Trackman PC
Mol Oncol; 2016 Jan; 10(1):1-23. PubMed ID: 26297052
[TBL] [Abstract][Full Text] [Related]
16. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth.
Pez F; Dayan F; Durivault J; Kaniewski B; Aimond G; Le Provost GS; Deux B; Clézardin P; Sommer P; Pouysségur J; Reynaud C
Cancer Res; 2011 Mar; 71(5):1647-57. PubMed ID: 21239473
[TBL] [Abstract][Full Text] [Related]
17. Expression of alpha 1,6-fucosyltransferase 8 in hepatitis B virus-related hepatocellular carcinoma influences tumour progression.
Ji J; Gu X; Fang M; Zhao Y; Yi C; Wang A; Gao C
Dig Liver Dis; 2013 May; 45(5):414-21. PubMed ID: 23352314
[TBL] [Abstract][Full Text] [Related]
18. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis.
Shieh TM; Lin SC; Liu CJ; Chang SS; Ku TH; Chang KW
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4378-85. PubMed ID: 17671119
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptide.
Eliades A; Papadantonakis N; Matsuura S; Mi R; Bais MV; Trackman P; Ravid K
Cell Cycle; 2013 Apr; 12(8):1242-50. PubMed ID: 23518500
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
Palamakumbura AH; Vora SR; Nugent MA; Kirsch KH; Sonenshein GE; Trackman PC
Oncogene; 2009 Sep; 28(38):3390-400. PubMed ID: 19597471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
